Top news of the week: 21.07.2020.
#biotechnology #CoronaOutbreak #COVID19 #CoronaPandemic #biospace #lifesciences #pharmaceuticals #CoronaVirus #Reapplix #biotech
Companies And Industries
Biopharma Update on the Novel Coronavirus: July 15
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/tVV1xr1sLn
OpenBiopharma Update on the Novel Coronavirus: July 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.
The top 10 highest paid biopharma R&D executives in 2019
Given drugmakers’ reliance on their R&D organizations, you might expect the companies with the biggest R&D budgets to match those paying their chief scientists the most. But that theory ...
Biopharma Update on the Novel Coronavirus: July 17
#biospace #lifesciences #biotechnology #pharmaceuticals
#Coronavirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/ZYJ3v4OL9K
OpenBiopharma Update on the Novel Coronavirus: July 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
Update: UK Biotech Imagen Set to Close Crowdcube Round With Nearly £900,000 Raised @crowdfundinside https://t.co/oeyztlsn8L
OpenUpdate: UK Biotech Imagen Set to Close Crowdcube Round With Nearly £900,000 Raised
Imagen, a UK-based biotech company, is set to close its equity crowdfunding campaign on Crowdcube with nearly £900,000 in funding secured. The funding round was launched last month ...
“The new funding is important because, with this significant capital raise, we can plan to a time horizon out through 2021 and into 2022, depending of course upon how fast we press on the accelerator.” #Reapplix #biotech
https://t.co/B8ccLVY5Ry
OpenDanish Wound Healing Biotech Raises €20M to Accelerate US Rollout
Reapplix, a Danish biotech focusing on developing wound healing technology, has raised €19.8M in equity funding to commercialize a treatment for diabetic foot ulcers in the US. The company ...
RT @Nanotechnology8: Future Analysis and Scope of Nanobiotechnology Market Industry to Drive Huge Growth by 2023 – Profiling Key Players Dendritic Nanotechnologies and SkyePharma Pharmaceuticals - Cole of Duty https://t.co/vWWNmY0rAc
OpenFuture Analysis and Scope of Nanobiotechnology Market Industry to Drive Huge Growth by 2023 – Profiling Key Players Dendritic Nanotechnologies and SkyePharma Pharmaceuticals
To perform the study, The Research Insights Research conducted primary as well as exhaustive secondary research. Ask for sample copy of this report @ …
Relay passes the baton from private to public biotech, making $400M in the process https://t.co/qi8tMCTXbt https://t.co/i8edNWwmtL
OpenRelay passes the baton from private to public biotech, making $400M in the process
Relay Therapeutics has pulled off a major upsized IPO worth $400 million to propel a pipeline of treatments aiming at previously undruggable targets.
Little-known Chinese firm builds $79M COVID-19 vaccine plant, eyes production next year https://t.co/JCdjCUIfx2
OpenLittle-known Chinese firm builds $79M COVID-19 vaccine plant, eyes production next year
No animal data, no word on the timeline for a clinical trial, yet one little-known Chinese company is already building a multimillion-dollar facility for a COVID-19 vaccine late-comer, even ...